ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.001,60
0,54%
S&P 500
5.127,79
1,26%
Dow Jones
38.675,68
1,18%
Euro vs US Dollar
1,07613
0,03%
Bitcoin
64.169,81
0,27%
Registration Strip Icon for charts Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Chimerix Inc (CMRX)

  7. Chimerix Inc (CMRX) News

CMRX Chimerix Inc

0,978
0,0278 (2,93%)
04 Mai 2024 - Geschlossen
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
Chimerix Inc CMRX NASDAQ Common Stock
  Änderung Änderung % Aktuell Zeit
Upgrade Icon
0,0278 2,93% 0,978 06:00:02
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
0,98 0,9374 0,98 0,9529 0,9502
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
01.5.202413:00GLOBEChimerix Reports First Quarter 2024 Financial Results and..
24.4.202413:00GLOBEChimerix to Report First Quarter 2024 Financial Results and..
16.4.202422:05GLOBEChimerix Reports Inducement Grants Under Nasdaq Listing Rule..
21.3.202412:00GLOBEChimerix Appoints Marc D. Kozin to Board of Directors
29.2.202415:20EDGAR2Form S-3 - Registration statement under Securities Act of..
29.2.202414:24EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
29.2.202413:58EDGAR2Form 8-K - Current report
29.2.202413:00GLOBEChimerix Reports Fourth Quarter and Year End 2023 Financial..
27.2.202413:00GLOBEChimerix to Present at TD Cowen 44th Annual Health Care..
22.2.202413:00GLOBEChimerix to Report Fourth Quarter and Year End 2023..
17.2.202402:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17.2.202402:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17.2.202402:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14.2.202423:01EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
14.2.202419:28EDGAR2Form 144 - Report of proposed sale of securities
14.2.202419:21EDGAR2Form 144 - Report of proposed sale of securities
14.2.202419:13EDGAR2Form 144 - Report of proposed sale of securities
12.2.202412:06EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
03.2.202400:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03.2.202400:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03.2.202400:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03.2.202400:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03.2.202400:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02.1.202417:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02.1.202417:07EDGAR2Form 3 - Initial statement of beneficial ownership of..
29.12.202322:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29.12.202322:51EDGAR2Form 8-K - Current report
29.12.202313:00GLOBEChimerix Appoints Lisa Decker to Board of Directors
04.12.202323:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04.12.202323:21EDGAR2Form 8-K - Current report
04.12.202313:00GLOBEChimerix Promotes Michelle LaSpaluto to Chief Financial..
24.11.202313:00GLOBEChimerix Reports Inducement Grant Under Nasdaq Listing Rule..
20.11.202321:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17.11.202300:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16.11.202322:15EDGAR2Form 8-K - Current report
16.11.202313:00GLOBEChimerix Strengthens Executive Leadership Team with..
13.11.202322:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02.11.202313:22EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
02.11.202313:02EDGAR2Form 8-K - Current report
02.11.202312:00GLOBEChimerix Reports Third Quarter 2023 Financial Results and..
26.10.202313:00GLOBEChimerix to Report Third Quarter 2023 Financial Results and..
29.9.202322:54EDGAR2Form SC 13G - Statement of acquisition of beneficial..
28.9.202322:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28.9.202319:22EDGAR2Form 144 - Report of proposed sale of securities
26.9.202321:58EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21.9.202300:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05.9.202313:00GLOBEChimerix to Participate in Upcoming Investor Conferences
16.8.202316:05GLOBEChimerix Announces Data Highlighting Clinical Efficacy and..
03.8.202313:30EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
03.8.202313:11EDGAR2Form 8-K - Current report

Kürzlich von Ihnen besucht

NASDAQ
CMRX
Chimerix
Delayed Upgrade Clock
ADVFN Logo

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten